IN.PACT™ Quality of Life Post-Reimbursement Study

NCT04597307 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-03-15

No results posted yet for this study

Summary

To prospectively collect and assess the perception of health-related Quality of Life, Pain and Walking Ability.

Conditions

  • Obstructive Disease
  • Atherosclerosis of Femoral Artery
  • Atherosclerosis of Popliteal Artery

Interventions

COMBINATION_PRODUCT

IN.PACT™ Admiral™ Drug Coated Balloon (DCB)

For percutaneous transluminal angioplasty (PTA) in subjects with obstructive disease of the peripheral arteries.

Sponsors & Collaborators

Principal Investigators

  • Prof. Yann Goueffic, MD, PhD · Hôpital Paris St Joseph

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-17
Primary Completion
2023-11-08
Completion
2024-12-31
FDA Device
Yes

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04597307 on ClinicalTrials.gov